Search
Search Results
##search.searchResults.foundPlural##
-
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1419PDF: 827HTML: 3124 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
1744PDF: 68HTML: 20 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1349PDF: 1240HTML: 461 -
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3656PDF: 903HTML: 6721 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1657PDF: 1105HTML: 127 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2198PDF: 1610HTML: 312 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4700PDF: 1330HTML: 1918Untitled: 184Untitled: 179 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3375PDF: 1486HTML: 4016 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1982PDF: 827HTML: 2206Table 1: 182Table 2: 202Table 3: 196Table 4: 201Table 5: 197Tble 6: 189Cover Letter: 210Greene Tab.7: 199 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1402HTML: 474PDF: 834 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1311PDF: 608HTML: 3104 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4136PDF: 1953HTML: 5325Table 1: 201 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2108PDF: 1167HTML: 647 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1702PDF: 819HTML: 938cover letter: 274 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1205PDF: 928HTML: 290 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1022PDF: 1011Suppl. Files: 641HTML: 146 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4816PDF: 2861HTML: 2310 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1356PDF: 627HTML: 266 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4405PDF: 924HTML: 1329Table1: 185 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1127PDF: 550HTML: 1698Figures: 173Fifures Sanz: 180tables Sanz: 184Untitled: 182 -
WHAT ARE FUNGAL INFECTIONS?
4242PDF: 2412HTML: 27631de Pauw: 241







